Global Prevalence of Osteoporosis in Chronic Kidney Disease: Protocol for a Systematic Review
Abstract
:1. Introduction
“A systemic disorder of mineral and bone metabolism due to CKD manifested by either one or a combination of the following: (i) abnormal metabolism of calcium, phosphorus, parathyroid hormone, or vitamin D; (ii) abnormalities in bone turnover, mineralization, volume, linear growth, or strength; (iii) vascular or other soft-tissue calcification [4].”
2. Materials and Methods
2.1. Protocol and Registration
2.2. Eligibility Criteria
2.2.1. Condition
2.2.2. Context
2.2.3. Participants (Population)
2.2.4. Types of Studies
2.3. Information Sources and Search Strategy
2.4. Study Selection
2.5. Data Extraction
- General information: author(s), year of publication, country, and language;
- Study design;
- Participants’ characteristics: sample size, mean or median age, proportions of female participants, ethnicity, stages of CKD, type of kidney replacement therapy, risk factors for osteoporosis (i.e., comorbidities, pharmacological therapy, and menopause, fracture history) and setting;
- Outcome information: prevalence of osteoporosis. Where only primary data (sample size and number of outcomes) are provided, these will be used to calculate the prevalence of the condition. For cohort studies that assess the prevalence of osteoporosis in CKD people, only data from the baseline will be extracted for analysis. Furthermore, the model of the device will be analyzed.
2.6. Assessment of Methodological Quality
2.7. Data Synthesis
2.8. Meta-Bias
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Appendix A
Query | Search | Records Retrieved |
---|---|---|
#1 | exp renal insufficiency, chronic/ | 117,737 |
#2 | ((kidney or renal) adj5 (insufficienc * or failure *)).tw,kf. | 126,769 |
#3 | (end?stage renal or end?stage kidney or chronic kidney or chronic renal).tw,kf. | 89,087 |
#4 | exp Renal Replacement Therapy/ | 213,825 |
#5 | ((renal or kidney) adj3 (transplant * or replacement *)).tw,kf. | 100,712 |
#6 | (predialysis or pre-dialysis or dialysis or hemodialys * or h?emofiltration or h?emodiafiltration or peritoneal dialys *).tw,kf. | 154,361 |
#7 | or/1–6 | 430,190 |
#8 | exp osteoporosis/ or bone density/ | 89,564 |
#9 | (osteoporo* or bone densit* or bone mineral densit* or bone mass or bone quantit* or bone quality or bone deminerali* or bone strength or bone los*).tw,kf. | 139,285 |
#10 | or/8–9 | 156,695 |
#11 | 7 and 10 | 3709 |
#12 | exp animals/ not humans/ | 4,776,757 |
#13 | 11 not 12 | 3544 |
#14 | exp clinical trial/ | 879,988 |
#15 | 13 not 14 | 3257 |
#16 | review.pt. | 2,750,483 |
#17 | 15 not 16 | 2330 |
References
- KDIGO CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. Suppl. 2013, 3, 1–150. [Google Scholar] [CrossRef] [Green Version]
- Hill, N.R.; Fatoba, S.T.; Oke, J.L.; Hirst, J.A.; O’Callaghan, C.A.; Lasserson, D.S.; Hobbs, F.D.R. Global Prevalence of Chronic Kidney Disease—A Systematic Review and Meta-Analysis. PLoS ONE 2016, 11, e0158765. [Google Scholar] [CrossRef] [PubMed]
- Bikbov, B.; Purcell, C.A.; Levey, A.S.; Smith, M.; Abdoli, A.; Abebe, M.; Adebayo, O.M.; Afarideh, M.; Agarwal, S.K.; Agudelo-Botero, M.; et al. Global, Regional, and National Burden of Chronic Kidney Disease, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017. Lancet 2020, 395, 709–733. [Google Scholar] [CrossRef] [Green Version]
- Moe, S.; Drüeke, T.; Cunningham, J.; Goodman, W.; Martin, K.; Olgaard, K.; Ott, S.; Sprague, S.; Lameire, N.; Eknoyan, G. Definition, Evaluation, and Classification of Renal Osteodystrophy: A Position Statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006, 69, 1945–1953. [Google Scholar] [CrossRef] [Green Version]
- Waziri, B.; Duarte, R.; Naicker, S. Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): Current Perspectives. Int. J. Nephrol. Renovasc. Dis. 2019, 12, 263–276. [Google Scholar] [CrossRef] [Green Version]
- Elder, G.J. Pathophysiology of CKD-MBD. Clin. Rev. Bone Miner. Metab. 2012, 10, 128–141. [Google Scholar] [CrossRef]
- Zheng, C.-M.; Zheng, J.-Q.; Wu, C.-C.; Lu, C.-L.; Shyu, J.; Yung-Ho, H.; Wu, M.-Y.; Chiu, I.-J.; Wang, Y.-H.; Lin, Y.-F.; et al. Bone Loss in Chronic Kidney Disease: Quantity or Quality? Bone 2016, 87, 57–70. [Google Scholar] [CrossRef]
- Hsu, C.-Y.; Chen, L.-R.; Chen, K.-H. Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review. Int. J. Mol. Sci. 2020, 21, 6846. [Google Scholar] [CrossRef]
- Covic, A.; Vervloet, M.; Massy, Z.A.; Torres, P.U.; Goldsmith, D.; Brandenburg, V.; Mazzaferro, S.; Evenepoel, P.; Bover, J.; Apetrii, M.; et al. Bone and Mineral Disorders in Chronic Kidney Disease: Implications for Cardiovascular Health and Ageing in the General Population. Lancet Diabetes Endocrinol. 2018, 6, 319–331. [Google Scholar] [CrossRef]
- Block, G.A. Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis. J. Am. Soc. Nephrol. 2004, 15, 2208–2218. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kim, S.M.; Long, J.; Montez-Rath, M.; Leonard, M.; Chertow, G.M. Hip Fracture in Patients with Non-Dialysis-Requiring Chronic Kidney Disease. J. Bone Miner. Res. 2016, 31, 1803–1809. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Klawansky, S.; Komaroff, E.; Cavanaugh, P.F.; Mitchell, D.Y.; Gordon, M.J.; Connelly, J.E.; Ross, S.D. Relationship between Age, Renal Function and Bone Mineral Density in the US Population. Osteoporos. Int. 2003, 14, 570–576. [Google Scholar] [CrossRef] [PubMed]
- Nickolas, T.L.; McMahon, D.J.; Shane, E. Relationship between Moderate to Severe Kidney Disease and Hip Fracture in the United States. J. Am. Soc. Nephrol. 2006, 17, 3223–3232. [Google Scholar] [CrossRef] [PubMed]
- Najar, M.S.; Mir, M.M.; Muzamil, M. Prevalence of Osteoporosis in Patients with Chronic Kidney Disease (Stages 3–5) in Comparison with Age- and Sex-Matched Controls: A Study from Kashmir Valley Tertiary Care Center. Saudi J. Kidney Dis. Transpl. 2017, 28, 538–544. [Google Scholar] [CrossRef]
- Aggarwal, H.K.; Jain, D.; Yadav, S.; Kaverappa, V. Bone Mineral Density in Patients with Predialysis Chronic Kidney Disease. Ren. Fail. 2013, 35, 1105–1111. [Google Scholar] [CrossRef]
- Huang, J.F.; Zheng, X.Q.; Sun, X.L.; Zhou, X.; Liu, J.; Li, Y.M.; Wang, X.Y.; Zhang, X.L.; Wu, A.M. Association between Bone Mineral Density and Severity of Chronic Kidney Disease. Int. J. Endocrinol. 2020, 2020. [Google Scholar] [CrossRef]
- de Carvalho, K.S.B.; Vasco, R.F.V.; Custodio, M.R.; Jorgetti, V.; Moysés, R.M.A.; Elias, R.M. Chronic Kidney Disease Is Associated with Low BMD at the Hip but Not at the Spine. Osteoporos. Int. 2019, 30, 1015–1023. [Google Scholar] [CrossRef]
- Iseri, K.; Qureshi, A.R.; Dai, L.; Ripsweden, J.; Heimbürger, O.; Barany, P.; Bergström, I.; Stenvinkel, P.; Brismar, T.B.; Lindholm, B. Bone Mineral Density at Different Sites and 5 Years Mortality in End-Stage Renal Disease Patients: A Cohort Study. Bone 2020, 130, 115075. [Google Scholar] [CrossRef]
- Yenchek, R.H.; Ix, J.H.; Shlipak, M.G.; Bauer, D.C.; Rianon, N.J.; Kritchevsky, S.B.; Harris, T.B.; Newman, A.B.; Cauley, J.A.; Fried, L.F. Bone Mineral Density and Fracture Risk in Older Individuals with CKD. Clin. J. Am. Soc. Nephrol. 2012, 7, 1130–1136. [Google Scholar] [CrossRef] [Green Version]
- Tentori, F.; McCullough, K.; Kilpatrick, R.D.; Bradbury, B.D.; Robinson, B.M.; Kerr, P.G.; Pisoni, R.L. High Rates of Death and Hospitalization Follow Bone Fracture among Hemodialysis Patients. Kidney Int. 2014, 85, 166–173. [Google Scholar] [CrossRef] [Green Version]
- Ketteler, M.; Block, G.A.; Evenepoel, P.; Fukagawa, M.; Herzog, C.A.; McCann, L.; Moe, S.M.; Shroff, R.; Tonelli, M.A.; Toussaint, N.D.; et al. Executive Summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: What’s Changed and Why It Matters. Kidney Int. 2017, 92, 26–36. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Evenepoel, P.; Cunningham, J.; Ferrari, S.; Haarhaus, M.; Javaid, M.K.; Lafage-Proust, M.-H.; Prieto-Alhambra, D.; Torres, P.U.; Cannata-Andia, J.; Vervloet, M.; et al. European Consensus Statement on the Diagnosis and Management of Osteoporosis in Chronic Kidney Disease Stages G4–G5D. Nephrol. Dial. Transplant. 2021, 36, 42–59. [Google Scholar] [CrossRef] [PubMed]
- Moher, D.; Shamseer, L.; Clarke, M.; Ghersi, D.; Liberati, A.; Petticrew, M.; Shekelle, P.; Stewart, L.A. Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 Statement. Syst. Rev. 2015, 4, 1. [Google Scholar] [CrossRef] [Green Version]
- Stroup, D.F.; Berlin, J.A.; Morton, S.C.; Olkin, I.; Williamson, D.; Rennie, D.; Moher, D.; Becker, B.J.; Sipe, T.A.; Thacker, S.B. Meta-Analysis of Observational Studies in Epidemiology: A Proposal for Reporting. JAMA 2000, 283, 2008–2012. [Google Scholar] [CrossRef]
- Munn, Z.; Moola, S.; Lisy, K.; Riitano, D.; Tufanaru, C. Methodological Guidance for Systematic Reviews of Observational Epidemiological Studies Reporting Prevalence and Cumulative Incidence Data. Int. J. Evid. Based Healthc. 2015, 13, 147–153. [Google Scholar] [CrossRef] [PubMed]
- Kanis, J.A.; Melton, L.J.; Christiansen, C.; Johnston, C.C.; Khaltaev, N. The Diagnosis of Osteoporosis. J. Bone Miner. Res. 2009, 9, 1137–1141. [Google Scholar] [CrossRef] [PubMed]
- Landis, J.R.; Koch, G.G. The Measurement of Observer Agreement for Categorical Data. Biometrics 1977, 33, 159. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D.G. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. J. Clin. Epidemiol. 2009, 62, 1006–1012. [Google Scholar] [CrossRef]
- Egger, M.; Smith, G.D.; Schneider, M.; Minder, C. Bias in Meta-Analysis Detected by a Simple, Graphical Test. BMJ 1997, 315, 629–634. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Duarte, M.P.; Ribeiro, H.S.; Neri, S.G.R.; Almeida, L.S.; Viana, J.L.; Lima, R.M. Global Prevalence of Osteoporosis in Chronic Kidney Disease: Protocol for a Systematic Review. Kidney Dial. 2021, 1, 47-52. https://doi.org/10.3390/kidneydial1010008
Duarte MP, Ribeiro HS, Neri SGR, Almeida LS, Viana JL, Lima RM. Global Prevalence of Osteoporosis in Chronic Kidney Disease: Protocol for a Systematic Review. Kidney and Dialysis. 2021; 1(1):47-52. https://doi.org/10.3390/kidneydial1010008
Chicago/Turabian StyleDuarte, Marvery P., Heitor S. Ribeiro, Silvia G. R. Neri, Lucas S. Almeida, João L. Viana, and Ricardo M. Lima. 2021. "Global Prevalence of Osteoporosis in Chronic Kidney Disease: Protocol for a Systematic Review" Kidney and Dialysis 1, no. 1: 47-52. https://doi.org/10.3390/kidneydial1010008